Curtis Tyree

Biography

Dr. Tyree is responsible for the management of progress vs. timelines for all Company programs and evaluates candidates from HUYA’s database of therapeutic opportunities. Dr. Tyree has over 20 years of drug discovery experience in oncology, cardiology, inflammatory disease, and neurology. At Ligand Pharmaceuticals and TorreyPines Therapeutics, Dr. Tyree worked on several significant projects with Abbott, GlaxoSmithKline, Bristol-Myers Squibb, and Eisai. He was a contributor to the discovery of Promacta, the first oral thrombopoietin receptor agonist as well as to the first published gamma secretase modulator for the treatment of Alzheimer’s disease. He received his B.Sc. from McGill University, Ph.D. in Biology from the University of California, San Diego, and performed postdoctoral research at the McArdle Laboratory for Cancer Research. He served 5 years as an instructor for UCSD Extension Bioscience. Dr. Tyree has been named a Business Advisor to the Hangzhou High Tech Incubator. Dr. Tyree is an Adjunct Clinical Assistant Professor of Pharmacy Practice and member of the Advisory Board at the Keck Graduate Institute School of Pharmacy

Research Interest

pharmaceutical